Iloperidone clinical trials
Also written Fanapt and VYV-683.
How each study uses iloperidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the iloperidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 6 May 2009 · FANAPT · NDA 022192 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2012 (5)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 15 · Other 5
Vanda Pharmaceuticals (10) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (2) · The University of Texas Health Science Center at San Antonio (1) · Maurizio Fava, MD (1) · New York State Psychiatric Institute (1) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Novartis (1) · Novartis Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antipsychotics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test iloperidone, phase 3 first.
- Nov 2027Randomized Withdrawal Study in Patients With SchizophreniaPhase 3 · Vanda Pharmaceuticals
Studies
Open first, then newest update. How each study uses iloperidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 20
- Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsRecruitingPhase 4Vanda PharmaceuticalsNCT05648591Written as Iloperidone
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionRecruitingPhase 2Vanda PharmaceuticalsNCT07090161Written as iloperidone
- Randomized Withdrawal Study in Patients With SchizophreniaRecruitingPhase 3Vanda PharmaceuticalsNCT06961968Written as iloperidone
- Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaCompletedPhase 3Vanda PharmaceuticalsNCT00254202Written as Iloperidone
- Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCompletedPhase 3Vanda PharmaceuticalsNCT04819776Written as Iloperidone
- A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease PsychosisWithdrawnPhase 2Vanda PharmaceuticalsNCT05344365Written as Iloperidone
- Relapse Prevention Study in Patients With SchizophreniaCompletedPhase 3Vanda PharmaceuticalsNCT01291511Written as Iloperidone
- A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of SchizophreniaCompletedPhase 1Vanda PharmaceuticalsNCT04712734Written as Iloperidone
- Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or SchizophreniaCompletedPhase 1Vanda PharmaceuticalsNCT04127058Written as Iloperidone
- Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)TerminatedPhase 2University of Colorado, DenverNCT01917318Written as Iloperidone
- Iloperidone in Mixed States of Bipolar DisorderCompletedPhase 4The University of Texas Health Science Center at San AntonioNCT02413918Written as iloperidone
- Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone TabletsStatus unknownPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT03420534Written as Iloperidone 1 MG
- Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and IrritabilityCompletedPhase 4Maurizio Fava, MDNCT01464229Written as Iloperidone
- Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or PlaceboCompletedPhase 4New York State Psychiatric InstituteNCT01920802Written as iloperidone
- Tolerability and Pharmacokinetics of Iloperidone in Adolescent PatientsCompletedPhase 1Vanda PharmaceuticalsNCT01495169Written as iloperidone (oral tablet)
- Assessing the Effects of Fanapt® on Social Cognition in SchizophreniaTerminatedPhase 4Northwestern UniversityNCT01929889Written as Iloperidone
- Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With SchizophreniaStatus unknownPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT02453893Written as Iloperidone
- Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat SchizophreniaCompletedPhase 2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT01623713Written as iloperidone
- Switching to Iloperidone From Other Antipsychotics in SchizophreniaCompletedPhase 4NovartisNCT01207414Written as iloperidone
- Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy VolunteersCompletedPhase 1Novartis PharmaceuticalsNCT01529294Written as Iloperidone
Given beside what is tested · 3 — iloperidone is usual care or a partner of the new treatment
- Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State ConditionsCompletedPhase 1Vanda PharmaceuticalsNCT06494397Written as VHX-896 and iloperidone
- Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy VolunteersCompletedPhase 1Vanda PharmaceuticalsNCT04969211Written as VHX-896 and iloperidone
- Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic PatientsCompletedPhase 1/2Novartis PharmaceuticalsNCT01348100Written as Oral iloperidone
Codes
What other systems call iloperidone · ClinicalTrials.gg INT003732
- MeSH (NLM) C081732iloperidoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VPO7KJ050NILOPERIDONEConfirmed FDA, NLM, Wikidata
- RxNorm 73178Confirmed FDA, Wikidata
- Wikidata Q4199443iloperidoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83784IloperidoneOne source FDA
- DrugBank DB04946One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C081732 | iloperidone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VPO7KJ050N | ILOPERIDONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 73178 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4199443 | iloperidone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83784 | Iloperidone | One source FDA |
| DrugBank | DB04946 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.